rss
Arch Dis Child Fetal Neonatal Ed 2004;89:F5-F8 doi:10.1136/fn.89.1.F5
  • Review

Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?

  1. P V Mohan1,
  2. W Tarnow-Mordi2,
  3. B Stenson3,
  4. P Brocklehurst4,
  5. K Haque5,
  6. V Cavendish6,
  7. A Cust7
  1. 1Department of Paediatrics, Baylor College of Medicine, Houston, TX 77025, USA
  2. 2Department of Neonatology, Westmead Hospital, and Children’s Hospital at Westmead, Sydney, NSW 2145, Australia
  3. 3The Royal infirmary of Edinburgh at Little France, Edinburgh, EH16 4SU, Scotland, UK
  4. 4National Perinatal Epidemiology Unit, Institute of Health Services, Oxford, OX3 7LF, UK
  5. 5Department of Child Health, Queen Mary’s Hospital for Children, Carshalton, Surrey SM5 1AA, UK
  6. 6Department of Clinical Sciences at North Bristol (Orthopaedic Surgery), University of Bristol, Bristol BS10 5NB, UK
  7. 7NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW 2006, Australia
  1. Correspondence to:
    Dr Mohan
    Department of Paediatrics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77025, USA; suseela12hotmail.com
  • Accepted 8 December 2002

Abstract

Recent evidence suggests that inflammatory cytokines may play an important role in cerebral and pulmonary injury, especially in preterm infants. Immunomodulatory agents may help to limit such injury by reducing inflammation. Immunoglobulin has multiple anti-inflammatory properties and can modulate the inflammatory cytokine response. New evidence is required to test the hypotheses that prophylaxis or treatment with intravenous immunoglobulin may limit such inflammatory damage.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.